Related Experiment Videos

Replication of primary HIV-1 isolates is inhibited in PM1 cells expressing sCD4-KDEL

S Degar1, J E Johnson, E Boritz

  • 1Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510, USA.

Virology
|December 15, 1996
PubMed

Insights

Soluble CD4 (sCD4-KDEL) effectively inhibits replication of primary HIV-1 isolates in cell lines. This finding supports gene therapy strategies for Acquired Immunodeficiency Syndrome (AIDS) treatment.

Area of Science:

  • Immunology
  • Virology
  • Gene Therapy

Background:

  • Previous studies showed soluble CD4 (sCD4-KDEL) blocked HIV-1MN strain propagation.
  • Primary HIV-1 isolates, more representative of infections, differ from cell-line-adapted strains.
  • The PM1 cell line propagates primary HIV-1 isolates without adaptation.

Purpose of the Study:

  • To evaluate sCD4-KDEL's efficacy against primary HIV-1 isolates.
  • To assess the potential of sCD4-KDEL for gene therapy in AIDS treatment.

Main Methods:

  • Utilized the PM1 cell line for primary HIV-1 isolate propagation.
  • Expressed sCD4-KDEL under the control of the HIV-1 Long Terminal Repeat (LTR).
  • Monitored HIV-1 replication by measuring reverse transcriptase activity.

Main Results:

  • Replication of four primary HIV-1 isolates was strongly inhibited in PM1 cells expressing sCD4-KDEL.
  • HIV-1 infection induced sCD4-KDEL expression driven by the LTR.
  • HIV-1 spread was dramatically reduced, with diminished reverse transcriptase activity.

Conclusions:

  • sCD4-KDEL is a potent inhibitor of primary HIV-1 replication.
  • sCD4-KDEL demonstrates promise for gene therapy-based treatment of AIDS.

Related Concept Videos